Areas of research include, but are not limited to, uncovering fundamental regulatory mechanisms that govern brain cancer development, regulate brain cancer stem-cell self-renewal and differentiation, drive invasion, and lead to treatment resistance. All state-of-the-art technologies are available including next-generation genomic and epigenomic testing, computational biology approaches, cell-based assays for drug screening, patient-derived cranial xenograft modeling, and small animal imaging.
Group Leader
Kevin Petrecca
